Alabama Cannabis Laws

Alabama Cannabis Laws: History, Legal Changes, and Current Rules

Updated October 10, 2026.

Alabama’s cannabis laws developed through narrow medical exceptions rather than broad recreational legalization. Early reforms focused on cannabidiol, or CBD, for severe medical conditions. In 2021, the state adopted a more comprehensive medical cannabis law, followed by years of licensing disputes and delayed implementation.

That distinction matters today: Alabama permits regulated medical cannabis, but recreational marijuana remains illegal. The state also regulates consumable hemp products through a separate system that changed substantially in 2025 and 2026.

This guide explains the history, current medical access, criminal possession rules, product restrictions, and recent hemp changes. It provides general legal information; individual cases depend on current law, regulations, and court orders.

Is Cannabis Legal in Alabama?

Alabama does not have a general adult-use marijuana market or a legal recreational possession allowance. Being 21 or older does not make ordinary marijuana possession lawful.

Registered patients and caregivers may obtain approved medical cannabis through the state’s regulated program. Protection depends on compliance with the Compassion Act and commission rules, as explained in Section 20-2A-4.

Alabama Cannabis Law Timeline

The Criminal-Law Foundation

Alabama’s criminal code distinguishes marijuana possession for personal use from possession for other purposes and from repeat personal-use offenses. The statutory history of the principal possession provisions traces them to Act 87-603.

Under Section 13A-12-214, unlawful possession for personal use is generally second-degree possession, a Class A misdemeanor, unless another authorization or applicable provision changes the analysis.

Under Section 13A-12-213, possession for other than personal use is a Class C felony. Personal-use possession after a qualifying prior possession conviction is a Class D felony.

The latter classification reflects a 2015 amendment. Medical legalization did not repeal these provisions for marijuana outside authorized circumstances. Alabama should therefore not be described as having generally decriminalized recreational possession.

2014: Carly’s Law and CBD Research

Carly’s Law was an early, narrowly targeted cannabis reform. It provided an affirmative defense involving qualifying CBD use associated with the University of Alabama at Birmingham’s neurology program.

The law responded to interest in CBD treatment for debilitating epileptic conditions. UAB’s research program became an important part of Alabama’s early medical cannabis discussion.

An affirmative defense is different from a general permission to purchase, sell, or possess any cannabis product. It provides a legal defense when its conditions are met; it does not create an unrestricted retail market.

The attorney general’s historical December 2018 guidance explains the limited scope of Carly’s Law. That document predates later hemp and medical cannabis reforms and should not be used as a complete statement of today’s CBD law.

2016: Leni’s Law

Leni’s Law broadened the earlier approach by creating a limited CBD affirmative defense for qualifying debilitating medical conditions, including specified circumstances involving minors and their parents or guardians.

The statutory text of Leni’s Law expressly distinguished that limited reform from generalized medical marijuana authorization. Its definition of CBD included specific compositional requirements.

The practical change was broader protection for certain medical CBD circumstances, rather than permission for recreational cannabis or a statewide dispensary industry. Carly’s Law, Leni’s Law, and the later Compassion Act represent separate stages of reform.

2021: The Compassion Act

On May 17, 2021, Alabama enacted the Darren Wesley “Ato” Hall Compassion Act. The law established a regulated medical cannabis system and the Alabama Medical Cannabis Commission, commonly called AMCC.

The framework covers physician certification, patient registration, caregiver access, and licensed commercial activities. It maintains substantial limits on the forms of cannabis patients may receive.

The Alabama Board of Medical Examiners’ medical cannabis guidance explains physician registration and certification requirements.

Passing the law did not immediately make products available. Alabama still needed regulations, licensed businesses, testing and supply arrangements, a registry, and operational dispensing sites.

2022–2026: Licensing Delays and the Start of Patient Access

The initial business-license application window closed on December 31, 2022. The commission subsequently considered applications across the program’s license categories.

On June 16, 2023, AMCC paused proceedings after discovering potential inconsistencies in scoring tabulations. Its official announcement explains that the pause affected award-related timelines and license issuance.

Further reconsideration and disputes extended implementation. This history illustrates the difference between a license award, actual license issuance, and a facility becoming operational.

AMCC reports that Alabama’s first medical cannabis dispensary opened on June 4, 2026. The commission’s current dispensary-status page documents that milestone.

Patients should verify each location’s operating status. A proposed site or a municipality appearing on a licensing list is not proof that a dispensary there is open and serving patients.

Who Qualifies for Medical Cannabis?

Medical access requires Alabama residency, a qualifying condition, certification by an approved physician, registration with AMCC, and compliance with card requirements.

People 19 and older can qualify to purchase through the patient program. Patients under 19 require a registered parent or legal guardian caregiver; their eligibility does not create independent purchasing rights.

The commission’s card eligibility guidance explains the basic requirements. A diagnosis alone does not complete enrollment.

Qualifying Conditions

AMCC’s patient information page lists qualifying conditions that include autism spectrum disorder, Crohn’s disease, depression, epilepsy or seizure conditions, panic disorder, Parkinson’s disease, PTSD, sickle cell anemia, Tourette’s syndrome, and terminal illness.

Other categories concern specified cancer-related symptoms, HIV/AIDS-related nausea or weight loss, certain forms of spasticity, persistent nausea subject to exclusions, and chronic or intractable pain meeting statutory treatment criteria.

The exact wording matters. For example, the nausea category includes exclusions, and the pain category includes conditions involving ineffective or contraindicated therapeutic intervention and opiate therapy. Patients should have eligibility assessed by a registered certifying physician.

How Registration Works

A registered certifying physician evaluates the patient and, if appropriate, enters the diagnosis and recommendation into the registry. The patient then completes registration and applies for a medical cannabis card.

A caregiver needs a separate application linked to the relevant physician-entered record. The commission describes this sequence in its registry process explanation.

Physician certification is a recommendation under the program, rather than an ordinary prescription that may be filled at any pharmacy. Patients should confirm the physician’s registration and the dispensing site’s authorization before arranging access.

Permitted and Prohibited Medical Products

Alabama’s medical system allows specified processed products rather than raw cannabis flower. Its formats differ substantially from medical programs in states that permit smoking or vaping.

AMCC’s product guidance describes these categories. An approved medical inhaler is not permission to use an ordinary cannabis vape cartridge.

Purchase, Possession, and THC Dosage Limits

Alabama measures medical access through daily dosages rather than a recreational flower allowance.

Under Section 20-2A-30, a patient or caregiver may not purchase more than 60 daily dosages, may not renew the supply more than 10 days before that period expires, and may not possess more than 70 daily dosages.

The general maximum recommended daily dosage is 50 milligrams of delta-9 THC. A physician may increase it to no more than 75 milligrams under the statutory conditions after 90 days of continuous care and medical cannabis use.

Terminal illness has a separate dosage exception. These rules appear in Section 20-2A-33. They are legal ceilings and exceptions, not instructions for selecting a personal dose.

A recommendation exceeding 75 milligrams under the terminal-illness provision triggers driver’s-license suspension requirements under Section 20-2A-34.

Home Growing, Sharing, and Diversion

Alabama’s patient program does not authorize home cultivation. Growing for the medical market requires the appropriate commercial license and compliance with the state’s regulated system.

A patient’s medical authorization also does not allow sharing products with friends or selling unused supplies. Section 20-2A-8 prohibits diversion and unauthorized activities involving medical cannabis.

Caregiver authority concerns obtaining and managing products for a registered patient. It does not create a general right for the caregiver to consume them.

2025–2026: A Separate System for Consumable Hemp

Alabama adopted Act 2025-385, originally House Bill 445, to regulate consumable hemp products. This law is separate from the medical cannabis program and should not be described as recreational marijuana legalization.

Effective January 1, 2026, consumable hemp retail sales require licensing through the Alabama Alcoholic Beverage Control Board. Sales are restricted to adults 21 and older. The ABC Board’s hemp guidance provides the current licensing framework.

Products must satisfy testing, packaging, labeling, and content requirements. Section 28-12-20 requires a corresponding independent laboratory certificate of analysis and compliance with the statutory product standards.

THC Content and Packaging

Under Section 28-12-23, beverages and edible products may contain no more than 10 milligrams of total THC per serving. Edible products must use individually wrapped single-serving packaging, with a maximum of 40 milligrams per carton.

Other covered topical, sublingual, or consumable products have a 40-milligram container limit. Beverage serving sizes and carton contents are also restricted.

Sales Channels and Inhalable Products

The 2025 legislation also prohibited smokable hemp products. Consumers should not assume hemp flower or a THC vape is lawful because its label says “hemp.”

Section 28-12-60 prohibits online sales, direct delivery, drive-through sales, and direct shipments of consumable hemp products within or into Alabama.

Medical cannabis rules, consumable hemp rules, and ordinary marijuana prohibitions must be considered separately. Compliance in one category does not authorize conduct in another.

Employment, Insurance, and Driving

The Compassion Act preserves broad employer authority. It does not require employers to accommodate medical cannabis use and does not prohibit adverse employment decisions based on that use.

Employers may maintain drug-testing policies. The law also does not require insurers or government assistance programs to reimburse medical cannabis expenses. These limits appear in Section 20-2A-6.

Lawful medical access does not authorize impaired driving. Patients must also account for the special driver’s-license consequences associated with the terminal-illness dosage exception.

Medical Cannabis Taxes

Alabama imposes a 9% tax on retail medical cannabis sales in addition to other applicable taxes. Section 20-2A-80 also establishes an annual medical cannabis privilege tax for businesses.

The business privilege tax is distinct from the tax associated with a patient’s purchase. The Department of Revenue provides business tax guidance for licensed operators.

Visitors and Interstate Travel

Alabama’s patient eligibility requirements include state residency. Visitors should not assume that a medical card from another state authorizes purchases or possession under Alabama’s program.

Products permitted elsewhere may also be prohibited Alabama formats. Medical flower or recreational cannabis purchased in another state does not become an approved Alabama product when brought across the border.

A medical recommendation is not blanket authorization for interstate transportation. Patients should verify Alabama eligibility and product rules instead of relying on another state’s possession allowance.

Alabama Law and Federal Cannabis Changes

Federal cannabis developments are separate from Alabama’s state-law requirements.

An April 28, 2026 federal final rule placed specified FDA-approved marijuana products and marijuana covered by qualifying state medical marijuana licenses in Schedule III. Marijuana outside that scope remains subject to Schedule I controls.

The broader rescheduling proceeding remained stayed under a September 2026 DEA order. These developments did not legalize recreational marijuana in Alabama or remove the state’s registry, licensing, product, and dosage requirements.

Frequently Asked Questions

Is recreational marijuana legal in Alabama?

No. The medical program does not establish general recreational possession or retail sales.

Are medical dispensaries operating?

AMCC reports the first dispensary opened June 4, 2026. Verify the operating status of the specific location before visiting.

Can patients smoke or vape medical cannabis?

No. The program excludes smoked and vaped products and raw plant material.

Can patients grow cannabis at home?

No. Patient registration does not authorize home cultivation.

Is a CBD or hemp label enough to establish legality?

No. Product contents, format, testing, packaging, seller licensing, and sales channel all matter under the separate hemp framework.

Understanding Alabama’s Evolving Cannabis Laws

Alabama moved from narrow CBD defenses to a regulated medical cannabis system while retaining recreational marijuana prohibitions. The long gap between the 2021 law and the first dispensary opening shows why legal authorization and practical availability must be distinguished.

For current decisions, identify whether the product falls under medical cannabis, consumable hemp, or ordinary marijuana law. Then check the applicable registration, product, possession, and sales requirements.